Drug Evaluation Committee Results of Questionnaire on Electronic Provision of Information -Trends in JPMA Participating Companies- (January 2023)

Pharmacovigilance Subcommittee

January 2024

With the VISION of "contributing to patient safety and security by establishing an ideal system for providing safety information from the viewpoints of patients and medical professionals and delivering necessary information," we are working to promote risk communication using DX. In January 2023, we conducted a survey of companies belonging to the JPMA PV Subcommittee to summarize the current status and issues regarding the provision of safety information to healthcare professionals using digital technology, and to make recommendations for more appropriate provision of safety information and information dissemination.

Survey results (please click here first)

Results of Questionnaire on Electronic Provision of Information: Trends among JPMA Participating Companies (conducted in January 2023) (1,538KB)

Supplementary Data

Results of the Questionnaire on the Electronic Provision of Information: Trends among JPMA Participating Companies (January 2023) (499KB)

Results of the Questionnaire on the Electronic Provision of Information: Trends among JPMA Participating Companies (January 2023) Attachment 2: List of Answers to the Open-Ended Questionnaire (314KB)

Back to All Deliverables

TOP